Cerity Partners’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $631K | Buy |
29,072
+231
| +0.8% | +$5.01K | ﹤0.01% | 1750 |
|
|
2025
Q1 | $699K | Buy |
28,841
+2,359
| +9% | +$57.2K | ﹤0.01% | 1582 |
|
|
2024
Q4 | $548K | Sell |
26,482
-2,251
| -8% | -$46.5K | ﹤0.01% | 1708 |
|
|
2024
Q3 | $571K | Buy |
28,733
+6,847
| +31% | +$136K | ﹤0.01% | 1706 |
|
|
2024
Q2 | $339K | Sell |
21,886
-940
| -4% | -$14.6K | ﹤0.01% | 1752 |
|
|
2024
Q1 | $364K | Buy |
22,826
+5,595
| +32% | +$89.2K | ﹤0.01% | 1763 |
|
|
2023
Q4 | $290K | Buy |
17,231
+1,780
| +12% | +$29.9K | ﹤0.01% | 1532 |
|
|
2023
Q3 | $181K | Buy |
+15,451
| New | +$181K | ﹤0.01% | 1289 |
|
|
2023
Q2 | – | Sell |
-554
| Closed | -$437K | – | 1700 |
|
|
2023
Q1 | $437K | Buy |
+554
| New | +$437K | ﹤0.01% | 1350 |
|